1. Home
  2. CPIX vs ORIS Comparison

CPIX vs ORIS Comparison

Compare CPIX & ORIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPIX
  • ORIS
  • Stock Information
  • Founded
  • CPIX 1999
  • ORIS 2014
  • Country
  • CPIX United States
  • ORIS China
  • Employees
  • CPIX N/A
  • ORIS N/A
  • Industry
  • CPIX Biotechnology: Pharmaceutical Preparations
  • ORIS Farming/Seeds/Milling
  • Sector
  • CPIX Health Care
  • ORIS Consumer Staples
  • Exchange
  • CPIX Nasdaq
  • ORIS Nasdaq
  • Market Cap
  • CPIX 40.1M
  • ORIS 19.5M
  • IPO Year
  • CPIX 2009
  • ORIS 2024
  • Fundamental
  • Price
  • CPIX $3.15
  • ORIS $0.65
  • Analyst Decision
  • CPIX
  • ORIS
  • Analyst Count
  • CPIX 0
  • ORIS 0
  • Target Price
  • CPIX N/A
  • ORIS N/A
  • AVG Volume (30 Days)
  • CPIX 110.2K
  • ORIS 181.9K
  • Earning Date
  • CPIX 08-05-2025
  • ORIS 02-21-2025
  • Dividend Yield
  • CPIX N/A
  • ORIS N/A
  • EPS Growth
  • CPIX N/A
  • ORIS N/A
  • EPS
  • CPIX N/A
  • ORIS 0.17
  • Revenue
  • CPIX $41,083,299.00
  • ORIS $15,014,000.00
  • Revenue This Year
  • CPIX N/A
  • ORIS N/A
  • Revenue Next Year
  • CPIX N/A
  • ORIS N/A
  • P/E Ratio
  • CPIX N/A
  • ORIS $3.98
  • Revenue Growth
  • CPIX 5.82
  • ORIS N/A
  • 52 Week Low
  • CPIX $1.04
  • ORIS $0.50
  • 52 Week High
  • CPIX $7.25
  • ORIS $56.01
  • Technical
  • Relative Strength Index (RSI)
  • CPIX 37.09
  • ORIS N/A
  • Support Level
  • CPIX $2.52
  • ORIS N/A
  • Resistance Level
  • CPIX $3.76
  • ORIS N/A
  • Average True Range (ATR)
  • CPIX 0.59
  • ORIS 0.00
  • MACD
  • CPIX -0.14
  • ORIS 0.00
  • Stochastic Oscillator
  • CPIX 19.39
  • ORIS 0.00

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About ORIS Oriental Rise Holdings Limited Ordinary Shares

Oriental Rise Holdings Ltd is an integrated supplier of tea products in China. It is principally engaged in the business of planting, cultivating, processing, and selling processed tea. The company currently produces and sells three categories of products: roughly processed white tea, roughly processed black tea, and refined tea. The company's business operations are vertically integrated, covering cultivation, processing of tea leaves, and the sale of tea products to tea business operators and end-user retail customers. Geographically, the company generates all of its revenue from its business in the People's Republic of China (the PRC).

Share on Social Networks: